FDA warns Empower over copying weight-loss drugs in inordinate amounts
AI Summary- FDA warned Empower Pharmacy over large-scale copying of weight-loss medicines.
- Empower’s production quantities were redacted from the warning letter.
- FDA ended the relevant drug shortage declaration in 2025.